Biocatalytic C7 Monomer Production Pathway
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a lack of economically cost-competitive petrochemical routes for producing monomers for Nylon 7 and Nylon 7,7, necessitating a sustainable biocatalytic approach to synthesize 7-aminoheptanoate, pimelic acid, 7-hydroxyheptanoate, heptamethylenediamine, and 1,7-heptanediol.
Innovation Solution
The use of polypeptides with specific enzymatic activities such as β-ketoacyl synthase, β-ketothiolase, 3-hydroxyacyl-CoA dehydrogenase, and other enzymes to biosynthesize these compounds through biochemical pathways in microorganisms, enabling the conversion of N-acetyl-5-amino-3-oxopentanoyl-CoA to 7-aminoheptanoate and subsequent conversion to other C7 building blocks like pimelic acid, 7-hydroxyheptanoate, and heptamethylenediamine.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If biocatalytic methods are used to produce C7 building blocks, then sustainability and economic competitiveness are improved, but process complexity increases due to multiple enzymatic steps required
Solution Approach 1:
The biocatalytic pathway is divided into distinct enzymatic segments, each catalyzing a specific transformation step from N-acetyl-5-amino-3-oxopentanoyl-CoA through various intermediates to final C7 building blocks. This segmentation allows for modular optimization of each enzymatic step while maintaining overall pathway functionality and economic viability
Solution Approach 2:
The patent employs a multi-functional enzymatic system where different polypeptides with specific activities (β-ketoacyl synthase, β-ketothiolase, dehydrogenase, hydratase, reductase, thioesterase, CoA-transferase, deacetylase, transaminase) work together in an integrated pathway. Each enzyme performs a specialized function that contributes to the overall production of multiple C7 building blocks from a common precursor, achieving universality in substrate utilization
2Adaptability or versatility
If multiple enzymatic conversion steps are implemented, then product diversity (multiple C7 building blocks) is improved, but manufacturing time and process duration increase
Solution Approach 1:
The pathway is designed to produce N-acetyl-5-amino-3-oxopentanoyl-CoA as a centralized intermediate that can be diverted to multiple product streams. This preliminary formation of a versatile intermediate allows subsequent branching to different C7 building blocks (7-aminoheptanoate, pimelic acid, 7-hydroxyheptanoate, heptamethylenediamine, 1,7-heptanediol) without requiring separate complete pathways for each product, thereby reducing overall manufacturing time
Solution Approach 2:
The biocatalytic pathway exhibits dynamic flexibility where enzyme expression levels, substrate availability, and product formation rates can be adjusted to optimize for different target products. The system can dynamically route metabolic flux toward different C7 building blocks based on demand, allowing versatile product production while minimizing total process duration through optimized pathway control
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a sustainable and efficient biocatalytic route for producing C7 building blocks, overcoming the economic limitations of petrochemical methods and enabling the production of essential monomers for Nylon synthesis.
Implementation Method 1
enzymatically converting N-acetyl-5-amino-3-oxopentanoyl-CoA or a salt thereof to 7-aminoheptanoic acid or a salt thereof using one or more polypeptides having the activity of a 3-hydroxyacyl-CoA dehydrogenase, an enoyl-CoA hydratase, a trans-2-enoyl-CoA reductase, a β-ketothiolase, a thioesterase or a CoA-transferase and a deacetylase or methods using microorganisms expressing one or more of such enzymes
Data Source
AI summary
This document describes biochemical pathways for producing 7-aminoheptanoic acid using a β-ketoacyl synthase or a β-ketothiolase to form an N-acetyl-5-amino-3-oxopentanoyl-CoA intermediate. 7-aminoheptanoic acid can be enzymatically converted to pimelic acid, 7-hydroxyheptanoic acid, heptamethylenediamine or 1,7-heptanediol or corresponding salts thereof. This document also describes recombinant microorganisms producing 7-aminoheptanoic acid as well as pimelic acid, 7-hydroxyheptanoic acid, heptamethylenediamine and 1,7-heptanediol or corresponding salts thereof.